Precise Biometrics AB (publ) (LON:0JDU)
3.066
-0.334 (-9.82%)
At close: Oct 7, 2025
Precise Biometrics AB Revenue
Precise Biometrics AB had revenue of 20.01M SEK in the quarter ending September 30, 2025, a decrease of -12.25%. This brings the company's revenue in the last twelve months to 82.58M, down -3.27% year-over-year. In the year 2024, Precise Biometrics AB had annual revenue of 86.85M with 15.70% growth.
Revenue (ttm)
82.58M SEK
Revenue Growth
-3.27%
P/S Ratio
2.17
Revenue / Employee
2.36M SEK
Employees
35
Market Cap
14.15M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 86.85M | 11.78M | 15.70% |
| Dec 31, 2023 | 75.07M | -15.95M | -17.52% |
| Dec 31, 2022 | 91.02M | 7.70M | 9.24% |
| Dec 31, 2021 | 83.32M | -9.03M | -9.78% |
| Dec 31, 2020 | 92.35M | 422.00K | 0.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |